AU2022353486A1 - Pharmaceutical composition containing triazine derivative - Google Patents
Pharmaceutical composition containing triazine derivative Download PDFInfo
- Publication number
- AU2022353486A1 AU2022353486A1 AU2022353486A AU2022353486A AU2022353486A1 AU 2022353486 A1 AU2022353486 A1 AU 2022353486A1 AU 2022353486 A AU2022353486 A AU 2022353486A AU 2022353486 A AU2022353486 A AU 2022353486A AU 2022353486 A1 AU2022353486 A1 AU 2022353486A1
- Authority
- AU
- Australia
- Prior art keywords
- compound
- substituted
- formula
- cov
- sars
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021-157929 | 2021-09-28 | ||
| JP2021157929 | 2021-09-28 | ||
| JP2021-171725 | 2021-10-20 | ||
| JP2021171725 | 2021-10-20 | ||
| JP2022-000723 | 2022-01-05 | ||
| JP2022000723 | 2022-01-05 | ||
| JP2022-015035 | 2022-02-02 | ||
| JP2022015035 | 2022-02-02 | ||
| JP2022131590 | 2022-08-22 | ||
| JP2022-131590 | 2022-08-22 | ||
| PCT/JP2022/035803 WO2023054292A1 (ja) | 2021-09-28 | 2022-09-27 | トリアジン誘導体を含有する医薬組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2022353486A1 true AU2022353486A1 (en) | 2024-05-02 |
Family
ID=85476839
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2022353486A Pending AU2022353486A1 (en) | 2021-09-28 | 2022-09-27 | Pharmaceutical composition containing triazine derivative |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250127788A1 (https=) |
| EP (1) | EP4410292A4 (https=) |
| JP (1) | JP7236065B1 (https=) |
| KR (1) | KR20240082359A (https=) |
| CN (1) | CN119818502A (https=) |
| AU (1) | AU2022353486A1 (https=) |
| CA (1) | CA3233206A1 (https=) |
| MX (1) | MX2024003600A (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT4122926T (lt) * | 2021-04-14 | 2025-07-25 | Shionogi & Co., Ltd. | Triazino dariniai, turintys virusų replikaciją slopinantį poveikį, ir juos apimanti farmacinė kompozicija |
| WO2023054732A2 (ja) * | 2022-01-19 | 2023-04-06 | 塩野義製薬株式会社 | 新型コロナウイルス感染症治療用医薬 |
| WO2024193451A1 (en) * | 2023-03-17 | 2024-09-26 | Ascletis BioScience Co., Ltd | Triazine derivatives, method of making and method of using thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999036410A1 (en) * | 1998-01-13 | 1999-07-22 | Scriptgen Pharmaceuticals, Inc. | Triazine antiviral compounds |
| PL2399910T3 (pl) | 2009-02-13 | 2014-09-30 | Shionogi & Co | Pochodne triazyny jako antagoniści receptora p2x3 i/albo p2x2/3 i kompozycja farmaceutyczna zawierająca je |
| CN103153968B (zh) | 2010-08-10 | 2016-02-03 | 盐野义制药株式会社 | 三唑衍生物及含有其的具有镇痛作用的药物组合物 |
| TW201331188A (zh) | 2011-12-15 | 2013-08-01 | Shionogi & Co | 經取代之三□衍生物及含有其之醫藥組成物 |
| TWI637949B (zh) | 2013-06-14 | 2018-10-11 | 塩野義製藥股份有限公司 | 胺基三衍生物及含有其等之醫藥組合物 |
| WO2019087884A1 (ja) * | 2017-10-31 | 2019-05-09 | 富士フイルム株式会社 | 組成物、抗菌組成物、抗ウイルス用組成物、抗ノロウイルス用組成物、スプレー、ワイパー |
| PH12021552872A1 (en) | 2020-04-05 | 2022-03-21 | Pfizer | Compounds and methods for the treatment of covid-19 |
| US11351149B2 (en) | 2020-09-03 | 2022-06-07 | Pfizer Inc. | Nitrile-containing antiviral compounds |
| EP4282420A4 (en) * | 2021-01-20 | 2024-11-27 | National University Corporation Hokkaido University | ANTIVIRAL AGENT |
| EP4313097A4 (en) * | 2021-03-29 | 2025-03-19 | Shireen Nature Company for General Trading, Ltd. | Willow extract and its use in treating coronavirus infection, inflammation, and associated medical conditions |
| LT4122926T (lt) * | 2021-04-14 | 2025-07-25 | Shionogi & Co., Ltd. | Triazino dariniai, turintys virusų replikaciją slopinantį poveikį, ir juos apimanti farmacinė kompozicija |
-
2022
- 2022-09-27 AU AU2022353486A patent/AU2022353486A1/en active Pending
- 2022-09-27 MX MX2024003600A patent/MX2024003600A/es unknown
- 2022-09-27 EP EP22876159.9A patent/EP4410292A4/en active Pending
- 2022-09-27 KR KR1020247013026A patent/KR20240082359A/ko active Pending
- 2022-09-27 JP JP2022565717A patent/JP7236065B1/ja active Active
- 2022-09-27 CA CA3233206A patent/CA3233206A1/en active Pending
- 2022-09-27 CN CN202510188695.9A patent/CN119818502A/zh active Pending
- 2022-09-27 US US18/696,097 patent/US20250127788A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN119818502A (zh) | 2025-04-15 |
| JP7236065B1 (ja) | 2023-03-09 |
| MX2024003600A (es) | 2024-04-09 |
| CA3233206A1 (en) | 2023-04-06 |
| US20250127788A1 (en) | 2025-04-24 |
| EP4410292A4 (en) | 2025-09-03 |
| KR20240082359A (ko) | 2024-06-10 |
| JPWO2023054292A1 (https=) | 2023-04-06 |
| EP4410292A1 (en) | 2024-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI815396B (zh) | 具有病毒增殖抑制作用之三嗪衍生物及含有其等之醫藥組合物 | |
| JP7466731B2 (ja) | トリアジン誘導体を含有する経口投与する製剤 | |
| WO2023054292A1 (ja) | トリアジン誘導体を含有する医薬組成物 | |
| AU2022353486A1 (en) | Pharmaceutical composition containing triazine derivative | |
| US20250025459A1 (en) | Covid-19 treatment medicine characterized by combining 3cl protease inhibitor and covid-19 treatment drug | |
| CN116514734A (zh) | 三嗪衍生物的制造方法和含有三嗪衍生物的口服给与的制剂 | |
| JP2024178473A (ja) | ウイルス増殖阻害活性を有する二環性含窒素複素環誘導体およびそれらを含有する医薬組成物 | |
| KR20240137021A (ko) | 신형 코로나바이러스 감염증 치료용 의약 | |
| JP7261529B1 (ja) | ウイルス増殖阻害作用を有するトリアジン誘導体の製造方法 | |
| CN116782904A (zh) | 含有三嗪衍生物的医药组合物 | |
| HK40114521A (en) | Pharmaceutical composition containing triazine derivative | |
| RU2806042C1 (ru) | Триазиновые производные, имеющие ингибиторную активность в отношении репликации вируса, и содержащая их фармацевтическая композиция | |
| AU2024307335A1 (en) | Pharmaceutical composition containing uracil derivative | |
| HK40081541A (en) | Triazine derivative having virus propagation inhibitory effect, and pharmaceutical composition containing same | |
| WO2025074997A1 (ja) | ウイルス増殖阻害活性を有する縮合複素環誘導体およびそれらを含有する医薬組成物 |